What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

Epilepsy and Behavior

Volumn 5, Issue 5, 2004, Pages 627-635

  Schmidt, Dieter ^a   Elger, Christian E ^b  

^a Arbeitsgruppe Epilepsieforschung   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Antiepileptic drugs; Carbamazepine; Epilepsy; Monotherapy; Oxcarbazepine; Partial seizures; Treatment of epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CARBAMAZEPINE; CHOLINERGIC RECEPTOR; CITALOPRAM; CLOBAZAM; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; DIHYDROPYRIDINE; FELBAMATE; GAMMA GLUTAMYLTRANSFERASE; GLUCURONOSYLTRANSFERASE; GONADOTROPIN; LAMOTRIGINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROID HORMONE; UNINDEXED DRUG; VALPROIC ACID; DRUG DERIVATIVE;

CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SUBSTITUTION; DRUG TOLERABILITY; ENDOCRINE DISEASE; EPILEPSY; FOCAL EPILEPSY; GLUCURONIDATION; HUMAN; MONOTHERAPY; OXIDATION; POSTMARKETING SURVEILLANCE; PROTEIN FUNCTION; RASH; REVIEW; RISK BENEFIT ANALYSIS; SODIUM CURRENT; STRUCTURE ANALYSIS; TERATOGENICITY; URINARY EXCRETION; ANIMAL; DRUG COMBINATION; DRUG INTERACTION;

ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; HUMANS;

EID: 15344351223     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.07.004     Document Type: Review

References (66)

1. W. Löscher D. Schmidt Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 17 1994 95-134
2. M. McLean Oxcarbazepine: Mechanism of action. In: R.H. Levy R.H. Mattson B.S. Meldrum E. Perucca, editors. Antiepileptic drugs 5th ed 2002 Lippincott Williams & Wilkins Philadelphia 451-458
3. 2+ channels in cultured rat hippocampus neurons stimulated with glutamate receptor antagonists Neuropharmacology 38 1999 1349-1359
4. A. Stefani A. Pisani M. De Murtas et al. Action of GP47779, the active metabolite of oxcarbazepine, on corticostriatal system: II. Modulation of high-voltage-activated calcium currents Epilepsia 336 1995 997-1002
5. 14C-oxcarbazepine in man Xenobiotica 16 1986 769-778
6. P. Lloyd G. Flesch W. Dieterle Clinical pharmacology and pharmacokinetics of oxcarbazepine Epilepsia 35 Suppl. 3 1994 S10-S13
7. M.C. Rouan J.B. Lecaillon J. Godbillon et al. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites Eur. J. Clin. Pharmacol. 47 1994 161-167
8. C. Fattore G. Cipolla C. Gatti et al. Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women Epilepsia 40 1999 783-787
9. A.E.H. Sonnen Oxcarbazepine and oral contraceptives Acta Neurol. Scand. 82 Suppl. 133 1990 37
10. L. Kramer Clinical expert report on the clinical documentation: Trileptal® 1998 Novartis Basel
11. A. Baruzzi F. Albani R. Riva Oxcarbazepine: Pharmacokinetic interactions and their clinical relevance Epilepsia 35 Suppl. 3 1994 S14-S19
12. E. Leinonen U. Lepola H. Koponen Substituting carbamazepine with oxcarbazepine increases citalopram levels: A report on two cases Pharmacopsychiatry 29 1996 156-158
13. V. Raitasuo R. Lehtovaara M.O. Huttunen Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics: A case report Psychopharmacology 116 1994 115-116
14. J.I.T. Isojärvi A.J. Pakarinen V.V. Myllyla Basic haematological parameters, serum gammaglutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy Seizure 6 1999 207-211
15. T.W. May B. Rambeck U. Jürgens Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with or without valproic acid comedications: Results of a retrospective study Ther Drug Monitor 21 1999 175-181
16. T.W. May E. Korn-Merker B. Rambeck Clinical pharmacokinetics of oxcarbazepine Clin. Pharmacokinet. 42 2003 1023-1042
17. P.H. Mogensen L. Jorgensen J. Boas et al. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites Acta Neurol. Scand. 85 1992 14-17
18. J.I.T. Isojärvi K.E.J. Airaksinen J.N. Mustonen et al. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine Epilepsia 36 1995 810-866
19. J.I.T. Isojärvi A.J. Pakarinen A. Rautio O. Pelkonen V.V. Myllyla Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine Epilepsia 35 1994 1217-1220
20. P.N. Patsalos J.M. Zakrzewska A.A. Elyas Dose-dependent enzyme induction by oxcarbazepine? Eur J Clin Pharmacol 39 1990 187-188
21. J. Rättyä L. Vainionpaa M. Knip et al. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy Pediatrics 103 1999 588-593
22. J. Rättyä J. Turkka A.J. Pakarinen et al. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy Neurology 56 2001 31-36
23. L.K. Vainionpää K. Mikkonen J. Rättya et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication Epilepsia 45 2004 197-203
24. B. Stoffel-Wagner J. Bauer D. Flügel et al. Serum sex-hormones are altered in patients with chronic focal epilepsies treated with anticonvulsant drugs Epilepsia 39 1998 1164-1173
25. J.I. Isojärvi A.J. Pakarainen A. Rautio et al. Serum sex hormone levels after replacing carbamazepine with oxcarbazepine Eur. J. Clin. Pharmacol. 47 1995 461-666
26. J.I.T. Isojärvi E. Löfgren K.S.T. Juntunen et al. Effect of epilepsy and antiepileptic drugs on male reproductive health Neurology 62 2004 247-253
27. K.J. Reinikainen T. Keranen T. Halonen et al. Comparison of oxcarbazepine and carbamazepine: A double-blind-study Epilepsy Res. 1 1987 284-289
28. D. Schmidt R. Sachdeo Oxcarbazepine for treatment of partial epilepsy: A review and recommendations for clinical use Epilepsy Behav. 1 2000 396-405
29. K. Wellingtonc K. Goa Oxcarbazepine: An update of its efficacy in the management of epilepsy CNS Drugs 15 2001 137-163
30. D. Schmidt C.E. Elger Differences between oxcarbazepine and carbmazepine Nervenarzt 75 2004 153-160
31. D. Schmidt C.E. Elger Oxcarbazepine (Trileptal). An effective and well tolerated new drug as first choice in treatment of focal seizures [Review] Nervenarzt 71 2000 849-855
32. L.M. Bang K.L. Goa Spotlight on oxcarbazepine in epilepsy CNS Drugs 18 2004 57-61
33. P.A. Bill U. Vigonius H. Pohlmann et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy Epilepsy Res. 27 1997 195-204
34. W. Christe G. Krämer U. Vigonius et al. A double-blind controlled clinical trial: Oxcarbazepine versus valproate in adults with newly diagnosed epilepsy Epilepsy Res. 26 1997 451-460
35. M.M. Guerreiro U. Vigonius H. Pohlmann et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy Epilepsy Res. 27 1997 205-213
36. M. Dam R. Ekberg Y. Löyning et al. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy Epilepsy Res. 3 1989 70-76
37. F. Albani B. Grassi R. Ferrara et al. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch Seizure 13 2004 254-630
38. G. Barcs E. Walker C.E. Elger et al. Oxcarbazepine: Placebo-controlled, dose-ranging trial in refractory partial epilepsy Epilepsia 41 2000 1597-1607
39. T. Glauser M. Nigro R. Sachdeo et al. Adjunctive therapy with oxcarbazepine in children with partial seizures Neurology 54 2000 2237-2244
40. Castillo S, Schmidt D, White S. Oxcarbazepine add-on drug for drug-resistant partial epilepsy [Cochrane review]. In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software
41. A.G. Marson J.L. Hutton J.P. Leach et al. Levetiracetam, oxcarbazepine, remacemide, and zonisamide for drug resistant localization-related epilepsy: Systematic review Epilepsy Res. 46 2001 259-270
42. R.C. Sachdeo T. Glauser J. Wheless M. Bebin A. Beydoun J. D'Souza Differential efficacy of oxcarbazepine and carbamazepine during adjunctive therapy in children with refractory partial seizures [Abstract 1.174] Epilepsia 43 Suppl. 7 2002 64
43. R.C. Sachdeo K. McCague J. D'Souza Oxcarbazepine (Trileptal®) is efficacious in patients with partial seizures when switching from carbamazepine or another AED [Abstract 2.277] Epilepsia 44 Suppl. 9 2003 271
44. V. Homberg A. Kowalik A. Schulze-Bonhage Ad Hoc-Umstellung von Carbamazepin auf Oxcarbazepin-Effektiviẗt und Tolerabiliẗt: Eine retrospektive Analyse Nervenarzt 72 2001 918-923
45. T. Glauser M. Nigro R. Sachdeo et al. Safety and efficacy of oxcarbazepine as adjunctive therapy in children with inadequately controlled partial seizures [Abstract 60.004] Neurology 52 Suppl. 2 1999 A392
46. P. Klosterskov-Jensen V. Saano P. Haring et al. Possible interaction between oxcarbazepine and an oral contraceptive Epilepsia 33 1992 1149-1152
47. J.A.P. Van Parys H. Meinardi Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal®) on a named-patient basis Epilepsy Res. 19 1994 79-85
48. R.G. Beran Cross-reactive skin eruption with both carbamazepine and oxcarbazepine Epilepsia 34 1993 163-165
49. P. Pienimaki E. Lampela J. Hakkola et al. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta Epilepsia 38 1997 309-316
50. M.L. Friis O. Kristensen J. Boas et al. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment Acta Neurol. Scand. 87 1993 224-227
51. R. Meischenguiser C.H. D'Giano S.M. Ferraro Oxcarbazepine in pregnancy: clinical experience in Argentina Epilepsy Behav. 5 2004 163-167
52. J. Jȩdrzejczak M. Greese-Łyko Evaluation of teratogenic effects of new generation of antiepileptic drugs Epilepsia 43 Suppl. 8 2002 158
53. J.I.T. Isojärvi M. Artana A. Auvinen Pregnancy outcomes in women with epilepsy treated with oxcarbazepine: A pilot study [Abstract 2.298] Epilepsia 44 Suppl. 9 2003 277
54. J. Peltola M. Kaartinen J. Uotila Oxcarbazepine (Trileptal®) and pregnancy outcomes: Report of a single-centre, retrospective study Eur. J. Neurol 10 Suppl. 1 2003 144
55. E. Kaaja R. Kaaja V. Hiilesmaa Major malformations in offspring of women with epilepsy Neurology 60 2003 575-579
56. National Institute for Clinical Excellence (NICE). Epilepsy: The diagnosis and management of epilepsy in children and adults. 2nd Consultation, March 2004, http://www.nice.org.uk/page.aspx?o=108913 Newer drugs for epilepsy in adults. March 2004, http://www.nice.org.uk/ page.aspx?o=110083
57. T. Van Amelsvoort R. Bakshi C.B. Devaux et al. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: A review Epilepsia 35 1994 181-188
58. B.F. Palmer J.R. Gates M. Lader Causes and management of hyponatremia Ann. Pharmacother. 37 2003 1694-1702
59. X. Dong J. White I.E. Leppik et al. Oxcarbazepine versus carbamazepine-induced hyponatremia: A follow-up study Neurology 60 Suppl. 1 2003 A431-A432
60. J.I.T. Isojärvi U.E.J. Huuskonen A.J. Pakarinen O. Vuolteenaho V.V. Myllylä The regulation of serum sodium after replacing carbamazepine with oxcarbazepine Epilepsia 42 2001 741-745
61. R.C. Sachdeo A. Wasserstein P.J. Mesenbrink J. D'Souza Effects of oxcarbazepine on sodium concentration and water handling Ann. Neurol. 51 2002 613-620
62. R.C. Sachdeo A.G. Wasserstein D'Souza Oxcarbazepine effect on sodium serum Epilepsia 40 Suppl. 79 1999 103
63. B. Bourgeois Safety and tolerability of oxcarbazepine (Trileptal®) in children with epilepsy [Abstract 2.290] Epilepsia 44 Suppl. 9 2003 275
64. D. Schmidt S. Arroyo M. Baulac et al. Recommendation on the clinical use of oxcarbazepine in the treatment of epilepsy Acta Neurol. Scand. 104 2001 167-170
65. J. Sidhu J. Ascher S. Job et al. Absence of pharmacokinetic drug interaction between lamotrigine and oxcarbazepine in healthy volunteers Epilepsia 45 Suppl. 3 2004 82
66. S.C. Schachter B. Vazquez R.S. Fisher et al. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures Neurology 52 1999 732-737